test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CIThe Cigna Group
Recent Activity
Exited
0%
$60.99M
184,500 shares@ $330.57 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
Exited
0%
$53.946M
222,000 shares@ $243.0 avg price
REGNRegeneron Pharmaceuticals
Recent Activity
Exited
0%
$50.449M
48,000 shares@ $1051.03 avg price
MRKMerck & Co Inc
Recent Activity
Exited
0%
$40.235M
325,000 shares@ $123.8 avg price
UTHRUnited Therapeutics Corp Del
Recent Activity
Exited
0%
$35.041M
110,000 shares@ $318.55 avg price
LNTHLantheus Hldgs Inc
Recent Activity
Exited
0%
$23.284M
290,000 shares@ $80.29 avg price
PCVXVaxcyte Inc
Recent Activity
Exited
0%
$21.445M
284,000 shares@ $75.51 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Exited
0%
$17.751M
782,000 shares@ $22.7 avg price
LEGNLegend Biotech Corp
Recent Activity
Exited
0%
$17.627M
398,000 shares@ $44.29 avg price
GILDGilead Sciences Inc
Recent Activity
Exited
0%
$17.496M
255,000 shares@ $68.61 avg price